“…Some progesterone derivatives increase allograft survival time (Hulka, Mohr & Lieberman, 1965;Peiner & Rhoades, 1965;Turcotte, Haines, Brody, Meyer & Schwarz, 1968) and have been shown to depress delayed type sensitivity (Carter, 1976). More recently progesterone has been shown to suppress P.P.D.-and P.H.A.-induced lymphocyte transformation (Wyle & Kent, 1977).…”